Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity
- 1 July 2006
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 16 (4) , 1552-1556
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Topoisomerase I-DNA Complexes Contribute to Arsenic Trioxide-induced ApoptosisJournal of Biological Chemistry, 2004
- NADH Oxidase Activation Is Involved in Arsenite-Induced Oxidative DNA Damage in Human Vascular Smooth Muscle CellsCirculation Research, 2000
- Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent PathwayBlood, 1999
- DNA topoisomerase IIα and -β expression in human ovarian cancerBritish Journal of Cancer, 1999
- Arsenic — New Life for an Old PotionNew England Journal of Medicine, 1998
- Multiple Drug Resistance Parameter Expression in Ovarian CancerGynecologic Oncology, 1998
- Human Topoisomerase II Function, Tyrosine Phosphorylation and Cell Cycle CheckpointsExperimental Biology and Medicine, 1998
- In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteinsBlood, 1996
- Physiologically based assessment of human exposure to urban air pollutants and its significance for public health risk evaluation.Environmental Health Perspectives, 1994